Stop-and-Frisk, Arrest, and Incarceration and STI/HIV Risk in Minority MSM

Information

  • Research Project
  • 10442045
  • ApplicationId
    10442045
  • Core Project Number
    R01DA044037
  • Full Project Number
    3R01DA044037-05S1
  • Serial Number
    044037
  • FOA Number
    PA-20-272
  • Sub Project Id
  • Project Start Date
    9/1/2021 - 2 years ago
  • Project End Date
    4/30/2022 - 2 years ago
  • Program Officer Name
    JENKINS, RICHARD A
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    4/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
    S1
  • Award Notice Date
    9/17/2021 - 2 years ago
Organizations

Stop-and-Frisk, Arrest, and Incarceration and STI/HIV Risk in Minority MSM

PARENT AWARD ABSTRACT Minority gay, bisexual, or other sexual minority men contend with stigma and discrimination based on sexual orientation and race, resulting in social isolation, and poverty risk that disproportionately impacts all minority groups. These factors contribute to mental/drug disorders, sex risk, and disproportionate STI/HIV, with half of black gay men and one-quarter of Hispanic gay men HIV-infected. Another prevalent structural determinant of STI/HIV that disproportionately affects minority MSM, yet that remains largely unexamined in this group, is criminal justice involvement (CJI). CJI for many minority MSM begins early in the life course with police stops and searches; our preliminary studies in New York City indicate one-third of minority MSM approximately 20 years of age have been stopped and searched (or ?frisked?) in the past 12 months. CJI evolves to arrest and detainment and for many, incarceration, with over half of some minority MSM groups experiencing jail or prison incarceration. Each step of the criminal justice process?being stopped by police, arrested, detained while awaiting trial often in over-crowded conditions, interacting with court-appointed lawyers?can be disempowering, demeaning, and for some may present physical threat. In other populations, CJI has been documented as a determinant of disrupted social and support networks, depression, substance use, and sex risk (leading to increased STI/HIV infection). Our understanding of pathways mediating associations between CJI and STI/HIV risk has informed development of programs for heterosexual minorities affected by CJI. This proposal is motivated by the prospect of developing policies and prevention programs for minority MSM. The effects of CJI on STI/HIV may differ for minority MSM; CJI may work synergistically with low social support, stigma/discrimination, and poverty to have particularly strong effects in this group. In addition, pathways linking CJI and STI/HIV risk also may differ for minority MSM. For example, while disruption of network ties may place minority MSM at risk, as we have observed in heterosexual minorities, other pathways may be equally critical because of high baseline risk of stigma and poverty. To address current critical gaps in our understanding of the effects of CJI on health, we have compiled a compendium of data sources to examine the effect of CJI on STI/HIV risk in minority MSM. Using the HIV Prevention Trials Network 061 (HPTN 061) cohort of black MSM and the Project 18 (P18) Cohorts 1 and 2 of minority MSM, we will evaluate longitudinal associations between multiple levels of CJI (stop-and-frisk, arrest, incarceration) and STI/HIV risk outcomes. We will describe the potential mediating roles of CJI-related disruption of social support networks, stigma, poverty, and resulting depression and substance use. In light of recent calls for changes to criminal justice policy, we aim to use computer simulation to model the impact of implementing polices to reduce CJI and improve correctional settings on HIV transmission in minority MSM and the larger population. Findings will inform evidence-based discussions about how to modify policy and programs to reduce HIV risk in a highly vulnerable population.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R01
  • Administering IC
    DA
  • Application Type
    3
  • Direct Cost Amount
    339877
  • Indirect Cost Amount
    151592
  • Total Cost
    491469
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIDA:491469\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
  • Study Section Name
  • Organization Name
    NEW YORK UNIVERSITY SCHOOL OF MEDICINE
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
    121911077
  • Organization City
    NEW YORK
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    10016
  • Organization District
    UNITED STATES